RVMD · Insider Trading

Revolution Medicines, Inc. Common Stock

Every open-market purchase and sale reported by RVMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
21
code S
Reporting Insiders
14
current holders
RVMD — Recent Form 4 Transactions (latest 2026-10-01)
FiledInsiderRole TypeSharesValue
2026-10-01 Alan B. Sandler Chief Development Officer MIXED −309 −$922.25K
2026-09-29 Jeff Cislini SVP & General Counsel Sell −765 −$158.60K
2026-09-28 Anthony Mancini See Remarks MIXED −587 −$638.36K
2026-09-24 Elizabeth M Anderson Director MIXED −5,073 −$1.95M
2026-09-22 Anthony Mancini See Remarks Sell −1,764 −$347.40K
2026-09-18 Jeff Cislini SVP & General Counsel Sell −3,366 −$670.63K
2026-09-18 Stephen Michael Kelsey See Remarks Sell −5,569 −$1.11M
2026-09-18 Mark A Goldsmith See Remarks Sell −13,988 −$2.79M
2026-09-18 Jack Anders Chief Financial Officer Sell −4,053 −$807.51K
2026-09-18 Alan B. Sandler Chief Development Officer Sell −341 −$67.94K
2026-09-18 Anthony Mancini See Remarks Sell −1,774 −$353.45K
2026-09-18 Margaret A Horn Chief Operating Officer Sell −4,967 −$989.61K
2026-09-15 Stephen Michael Kelsey See Remarks MIXED — −$14.87M
2026-09-14 Anthony Mancini See Remarks MIXED −6,085 −$2.84M
2026-09-10 Lorence H. Kim Director Sell −17,090 −$3.59M
2026-09-02 Lorence H. Kim Director Sell −56,000 −$11.38M
2026-08-25 Jeff Cislini General Counsel MIXED −614 −$10.78M
2026-08-25 Mark A Goldsmith See Remarks MIXED −6,000 −$17.61M
2026-07-01 Sushil Patel Director MIXED −2,625 −$938.04K
2026-06-26 Jack Anders Chief Financial Officer MIXED — −$3.00M
2026-06-23 Sushil Patel Director A +1,191 —
2026-06-23 Alexis Borisy Director A +1,191 —
2026-06-23 Flavia Borellini Director A +1,191 —
2026-06-23 Sandra Horning Director A +1,191 —
2026-06-23 Lorence H. Kim Director A +1,191 —
2026-06-23 Elizabeth M Anderson Director A +1,191 —
2026-06-23 Frank Clyburn Director A +1,191 —
2023-11-14 Thilo Schroeder Director A +1,457,211 —
2023-11-14 Alexis Borisy Director A +2,091,672 —
2023-11-14 Sandra Horning Director A +90,487 —
2023-10-25 Margaret A Horn Chief Operating Officer M +7,500 +$4.05K
2023-10-24 Mark A Goldsmith See Remarks M +35,000 +$17.15K
2023-10-23 Jack Anders Chief Financial Officer M +24,524 +$72.97K
2023-10-18 Margaret A Horn Chief Operating Officer MIXED — −$746.56K
2023-10-13 Stephen Michael Kelsey See Remarks Sell −16,667 −$484.13K
2023-10-02 Jeff Cislini General Counsel Sell −2,000 −$56.39K
2023-09-20 Jack Anders Chief Financial Officer Sell −1,427 −$44.68K
2023-09-20 Jeff Cislini General Counsel Sell −1,214 −$38.01K
2023-09-20 Mark A Goldsmith See Remarks Sell −8,054 −$252.17K
2023-09-20 Stephen Michael Kelsey See Remarks Sell −2,060 −$64.50K
2023-09-19 Margaret A Horn Chief Operating Officer MIXED −2,514 −$218.67K
2023-09-06 Jack Anders Chief Financial Officer MIXED — −$647.49K
2023-09-06 Barbara Weber Director MIXED — −$468.96K
2023-09-06 Mark A Goldsmith See Remarks MIXED −10,000 −$1.38M
2023-09-01 Margaret A Horn Chief Operating Officer MIXED — −$299.56K
2023-08-17 Margaret A Horn Chief Operating Officer MIXED — −$132.18K
2023-08-03 Stephen Michael Kelsey See Remarks Sell −33,332 −$1.03M
2023-08-01 Jeff Cislini General Counsel Sell −1,500 −$39.03K
2023-06-22 Jeff Cislini General Counsel Sell −1,239 −$31.15K
2023-06-22 Jack Anders Chief Financial Officer Sell −1,249 −$31.09K
RVMD — Current Insider Holders
InsiderRole Shares HeldValue
Alexis Borisy Director 2,340,075 $468.74M
Mark A Goldsmith See Remarks 861,177 $172.50M
Stephen Michael Kelsey See Remarks 286,307 $57.35M
Margaret A Horn Chief Operating Officer 154,571 $30.96M
Jack Anders Chief Financial Officer 123,208 $24.68M
Sandra Horning Director 97,765 $19.58M
Alan B. Sandler Chief Development Officer 52,559 $10.53M
Jeff Cislini SVP & General Counsel 51,776 $10.37M
Anthony Mancini See Remarks 39,765 $7.97M
Flavia Borellini Director 26,215 $5.25M
Sushil Patel Director 21,656 $4.34M
Elizabeth M Anderson Director 20,933 $4.19M
Lorence H. Kim Director 16,576 $3.32M
Frank Clyburn Director 10,929 $2.19M
RVMD Insider Trading FAQ
Who are the insiders at RVMD?
14 officers, directors and 10%+ beneficial owners currently report holdings in RVMD via SEC Form 4.
Are RVMD insiders buying or selling?
Across the 50 most recent Form 4 filings for RVMD, 0 were open-market purchases (code P) and 21 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is RVMD insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent RVMD filing is dated 2026-10-01.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the RVMD quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.